Below are the most recent publications written about "Antineoplastic Agents" by people in Profiles.
-
Shields CL, Medina R, Evans H, Valdes-Perez N, Acar AB, Bansal R, Lally SE, Shields JA. HIGH-DOSE INTRAVITREAL TOPOTECAN FOR RECURRENT RETINOBLASTOMA, SUBRETINAL SEEDS, AND VITREOUS SEEDS. Retina. 2025 01 01; 45(1):1-6.
-
Alshahrani AA, Kontopantelis E, Morgan C, Ravindrarajah R, Martin GP, Mamas MA. Cardiovascular diseases in patients with cancer: A comprehensive review of epidemiological trends, cardiac complications, and prognostic implications. Chin Med J (Engl). 2025 Jan 20; 138(2):143-154.
-
Udumula MP, Rashid F, Singh H, Pardee T, Luther S, Bhardwaj T, Anjaly K, Piloni S, Hijaz M, Gogoi R, Philip PA, Munkarah AR, Giri S, Rattan R. Targeting mitochondrial metabolism with CPI-613 in chemoresistant ovarian tumors. J Ovarian Res. 2024 Nov 14; 17(1):226.
-
Mondal A, Das B, Karmakar S, Pani S, Khan S, Gupta P, Das Sarma J. Modulatory Role of Pantropic Cell Signaling Pathways in the Antimigratory and Antiproliferative Action of Triazole Chelated Iridium(III) Complexes in Cervical Cancer Cells. J Med Chem. 2024 11 28; 67(22):20559-20570.
-
Ippolito M, Hayduk SA, Kinney W, Brenneman DE, Ward SJ. KLS-13019, a Novel Structural Analogue of Cannabidiol and GPR55 Receptor Antagonist, Prevents and Reverses Chemotherapy-Induced Peripheral Neuropathy in Rats. J Pharmacol Exp Ther. 2024 10 18; 391(2):231-240.
-
Rahmani Khalili N, Badiei A, Pirkani Z, Mohammadi Ziarani G, Vojoudi H, Golmohamadi A, Varma RS. Double-shelled, rattle-architecture covalent organic framework: harnessing morphological manipulation for enhanced synergistic multi-drug chemo-photothermal cancer therapy. J Mater Chem B. 2024 Aug 14; 12(32):7915-7933.
-
Brose MS, Capdevila J, Elisei R, Bastholt L, F?hrer-Sakel D, Leboulleux S, Sugitani I, Taylor MH, Wang Z, Wirth LJ, Worden FP, Bernard J, Caferra P, Colzani RM, Liu S, Schlumberger M. Vandetanib in locally advanced or metastatic differentiated thyroid cancer refractory to radioiodine therapy. Endocr Relat Cancer. 2024 08 01; 31(8).
-
Nicol? E, Gandini S, Giugliano F, Uliano J, D'Ecclesiis O, Morganti S, Ferraro E, Trapani D, Tarantino P, Zagami P, Boldrini L, Caramella I, Carnevale Schianca A, Cristofanilli M, Locatelli MA, Esposito A, Belli C, Minchella I, Criscitiello C, Marra A, Curigliano G. Effect of age on safety and efficacy of novel cancer drugs investigated in early-phase clinical trials. Eur J Cancer. 2024 Aug; 207:114181.
-
Kennedy AS, Brown DB, Fakih M, Jeyarajah R, Jones S, Liu D, Pinato DJ, Sangro B, Sharma NK, Sze DY, Van Cutsem E, Wasan HS. Multidisciplinary Delphi Consensus on Safety of Combining Transarterial Radioembolization with Yttrium-90 Microspheres with Systemic Anticancer Agents for the?Treatment of Liver Malignancy. J Vasc Interv Radiol. 2024 09; 35(9):1253-1267.e1.
-
Ozaki M, Kageyama K, Kimura K, Eguchi S, Yamamoto A, Tanaka R, Nota T, Yonezawa H, Nishiofuku H, Sakai Y, Tani N, Jogo A, Terai M, Sato T, Ishizawa T, Miki Y. A rat-based preclinical platform facilitating transcatheter hepatic arterial infusion in immunodeficient rats with liver xenografts of patient-derived pancreatic ductal adenocarcinoma. Sci Rep. 2024 05 08; 14(1):10529.